ClinVar Miner

Submissions for variant NM_001033855.3(DCLRE1C):c.346T>C (p.Cys116Arg)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen RCV002302853 SCV004102782 likely pathogenic Severe combined immunodeficiency due to DCLRE1C deficiency 2023-11-14 reviewed by expert panel curation The NM_001033855.3:c.436T>C variant in DCLRE1C is a missense variant predicted to cause the substitution of cysteine by arginine at amino acid 116 (p.Cys116Arg). This variant is absent from gnomAD and therefore has a population max filtering allele frequency that is below the threshold for PM2_Supporting set by the ClinGen SCID VCEP for DCLRE1C (<0.00003266). This variant has been reported in an individual with SCID (PMID: 36546626). ART012: As per inclusion criteria in supplement files in PMID: 36546626, diagnostic criteria for SCID/leaky SCID is met (0.5 points), and phenotype was corrected by lentiviral gene therapy (CNV test performed, unpublish data) (7 points). Additional information from Dr. Cowan (unpublished): radiation sensitivity testing in the patient's fibroblasts and demonstrated that the Artemis vector (AProArt) corrected the radiation sensitivity both in terms of proliferation and gH2AX production - therefore 2 additional points added as per specification "Vector-based complementation corrected increased cellular radiosensitivity and/or decreased VDJ recombination." Therefore the total from this patient, by PMID plus unpublished data, is = 9.5 points = PP4_Strong. In this individual, the variant co-occurred in trans with a second variant c.161+2T>G, which would be classified as Likely Pathogenic by the ClinGen SCID VCEP; therefore, PM3 is met (1p). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive SCID based on the ACMG criteria applied: PM2_Supporting, PP4_Strong, and PM3 as specified by the ClinGen SCID VCEP (VCEP specifications version 1).
Cowan and Puck Lab, Allergy Immunology and BMT Division, UCSF Benioff Children's Hospital RCV002302853 SCV002589114 pathogenic Severe combined immunodeficiency due to DCLRE1C deficiency 2021-03-23 criteria provided, single submitter clinical testing 1 PS3(functional study: Cowan M, Puck J, Unpublished data); 1 PM3(in trans with pathogenic variant); 1 PM2(rare); 1 PP3(Polyphen 1.0 damaging); 1 PP4(phenotype consistent)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.